Armin Garmany (@ArminGarmany) header
Armin Garmany (@ArminGarmany) profile picture

MD-PhD Candidate @MayoClinicSOM MSTP; Interested in cardiology and regenerative medicine. Views are mine.

Joined March 2020
Photo by Armin Garmany (@ArminGarmany)
Nonatherothrombotic causes of #cvMI events, especially spontaneous coronary artery dissection, were more common in younger women than younger men, according to a community-based study published in #JACC. Read the journal scan for more ➡️ bit.ly/3KjOvn1 #HeartFailure
2
12
24
4,016
PKP2-ACM is associated with a distinct ventricular arrhythmia pattern on exercise stress test that may carry prognostic significance. Strong work in @JACCJournals from @MayoClinicCV fellow @MCastrichiniMD and the @MayoClinicWSRGH team! authors.elsevier.com/a/1ljK1…
3
5
21
1,479
Not all ⁦LMNA⁩ missense variants are lower risk. Variants involving p.Arg471 and p.Arg541 in the IgD domain result in a distinct LGE pattern and increased risk of VA/stroke. Big shootout to ⁦@MayoClinicCV⁩ CI fellow ⁦@MCastrichiniMD⁩! ahajournals.org/doi/epub/10.…
2
5
1
20
2,794
This AI screening model used only an apical 4ch echo videoclip & effectively differentiated cardiac amyloidosis from other causes of ⬆️ wall thickness
📢 New #EHJ study! Our AI screening tool for echo — EchoGo® Amyloidosis — detects cardiac amyloidosis, a life-threatening condition, with high accuracy. Developed with @MayoClinic @UChicago, tested with 18 global sites. See paper & release: ultromics.com/press-releases… #CardioTwitter
5
14
45
3,464
Our FDA-approved AI echo model to detect HFpEF from an apical 4-ch videoclip also works with handheld US! @ultromics @MayoClinicCV @JournalASEcho Application of an Artificial Intelligence Model to Detect Heart Failur... sciencedirect.com/science/ar…
16
45
3,114
Armin Garmany retweeted
RBM20 cardiomyopathy carries a more significant burden at a younger age, and an accelerated course compared to TTN cardiomyopathy pmc.ncbi.nlm.nih.gov/article… #CardioTwitter
5
17
1,415
🔎Case Study: RV #PVLoops used to assess cardiac function during an #LVAD ramp. #PVloop #hemodynamics offer deeper insights into heart mechanics, improving diagnostic accuracy, and guiding treatment strategies. 📖lnkd.in/dcRkWb8C #lvad #cardiotwitter #heartfailure #mcs
5
9
1,008
Glad to see our @JAMANetworkOpen study out. The study brings attention to the growing healthspan-lifespan gap across the world and reveals the largest gap in the US. The study documents a larger healthspan-lifespan gap in women associated with a disease burden disparity.
The global healthspan-lifespan gap has widened to 9.6 years over the past two decades, with women experiencing a larger gap than men, and is associated with increased noncommunicable diseases and overall morbidity, particularly in the US. ja.ma/4inyvwV
4
3
18
1,472
Congratulations @GarmanyRamin, very interesting!
Happy to see our manuscript characterizing sex-specific differences in the multi-omics profile of HCM officially published! Grateful to @MJAckermanMDPhD and my co-authors for making this possible. sciencedirect.com/science/ar…
5
371
Armin Garmany retweeted
.@MayoClinic research is investigating the health effects of space travel on private citizens. A @MayoProceedings @ArminGarmany paper shares findings of the health response of the first all-civilian astronaut mission to the International Space Station. mayocl.in/3MEkZWJ
2
2
7
1,360
Thank you for the privilege to be one of your trainees @MJAckermanMDPhD! Grateful to you and the rest of your team for all the opportunities to grow both personally and professionally during my PhD.
In the life of a mentor, this past wk was unforgettable. 3 of my PhD students: ⁦@XGaoKevin⁩ ⁦@GarmanyRamin⁩ & ⁦@sahejbains⁩ successfully defended their PhD thesis. I started as their adviser, grew into their mentor, and became their “father”. So PROUD of them!
1
2
19
1,295
⁦@GarmanyRamin⁩ put together an awesome poster about the multi-omic architecture in #HCM. Check out part of the story in ⁦@Circ_Gen⁩. This next layer of microRNA presented here @hrsonline ##HRS2023 furthers the blueprint for novel therapies. Ramin is AMAZING.
1
7
2
32
4,379
⁦⁦@MartinaGluscevi⁩ presented some provocative insights wrt intracellular calcium handling in re-engineered #heart cells from patients w/ type 2 LQTS. So many ⁦@HRSonline⁩ #HRS2023 attendees were riveted by the data especially ⁦@BehrElijah⁩
1
6
22
3,027
Congratulations @GarmanyRamin! Very interesting work studying the proteomic and transcriptomic landscape of HCM.
Now online from @MJAckermanMDPhD + team: Multi-Omic Architecture of Obstructive Hypertrophic Cardiomyopathy ahajournals.org/doi/10.1161/… @AHAScience #AHAjournals #CardioTwitter #MedTwitter Video abstract will be posted soon!
1
11
737
Congratulations; great work!
Excited to share our study from @MayoClinicCV looking at the role of cardiopulmonary exercise testing in athletes with #HCM! Grateful to Drs. Newman, @MJAckermanMDPhD @jeffreygeske, @SteveOmmen, and all the other authors. sciencedirect.com/science/ar…
1
9
And that’s a wrap for day 2 here @AHAScience #AHA22. My @MayoClinicSOM MD/PhD student @GarmanyRamin spoke on RBM20-mediated cardiomyopathy. Wonderful collaboration w/ my dear friend @nl_pereira from @MayoClinicCV. Very grateful to be surrounded by amazing students like Ramin. – at Chicago, IL
4
1
23
Very exciting and comprehensive study published @NatureComms on how vital Vitamin C is, especially its epigenetic functions, to bone and bone cell differentiation & properties! Many congrats to @RomanThaler and team at @MayoClinic! nature.com/articles/s41467-0…
1
14
49